mAb Process Development and Optimization
-
Scalable By Design: Streamlining Cell Culture Media Manufacturing
8/15/2024
Learn ways to help improve quality, simplify technology transfer of proprietary media formulations, and mitigate logistical challenges associated with custom media scale-up processes.
-
Cytovance Customer Testimonial: Thermo Scientific Single-Use Technologies
12/8/2020
Thermo Fisher Scientific has served as a key partner in the bioprocess industry, by establishing manufacturing and development capabilities, enabling Cytovance Biologics to expand offerings their product offering, to better serve clients with diverse pharmaceutical needs. In this video, the imPULSE Single-Use Mixer is highlighted for protein refolding applications at a 30 L scale and then transferred to manufacturing operations up to 5,000 L scale.
-
The Role Of Peptones In Boosting Quality And Yield
11/4/2024
Peptones can significantly boost CHO cell bioprocessing. We analyze their impact on diverse CHO cell lines using real-world data to assess their effects on titer, protein quality, and cell growth.
-
An Innovative Approach To High Aggregate Challenges
7/14/2025
In this webinar, hear from a technical specialist on addressing the challenges with antibody aggregates and process related impurity removal using a new high performance chromatography resins
-
Next-Gen Medium And Feeds System To Improve CHO Cell Line Productivity
6/19/2024
Choose the right CHO medium and feed system to optimize your upstream processes and secure a seamless scaling up.
-
Addressing Post-Translational Modifications In Novel Protein Therapeutics
9/13/2024
Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech, addresses an audience question on conjugation efficiencies in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics. From there, we move on to an audience-led discussion on when to initially address titer, PTMS, and product quality during development of novel protein therapeutic cell lines, with Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio and Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics weighing in.
-
Upstream To Downstream: A Comprehensive Approach To AAV Production
12/7/2023
How can you face the challenges of AAV production, scale up your AAV manufacturing effectively, and enhance the recovery and purity in your downstream processing.
-
mAb Up- And Downstream Process Intensification Strategies
12/12/2024
Discover how to reduce monoclonal antibody (mAb) manufacturing time and costs through process intensification. Learn about continuous perfusion, ultrahigh cell density banks, and more.
-
Considerations In Continuous Chromatography
8/27/2024
In this segment of the Bioprocess Online Live event Bioprocess Intensification In The Real World, our presenters discuss considerations for continuous versus batch chromatography and compare notes on the approaches at their respective organizations.
-
The Way Forward: Supply Chain Solutions
10/24/2024
Learn how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions.